Yajing Yang

AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer

Michael J. Giffin, Keegan S. Cooke, Edward K. Lobenhofer et al. · Clinical Cancer Research · 2020 · 238 citations · Full text

Medicine, Oncology, Pharmacology +15

D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1

Ruonan Zhang, Yajing Yang, Wenjing Dong et al. · Proceedings of the National Academy of Sciences · 2022 · 234 citations · Full text

Medicine, Immunology, Oncology +17

Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase

Brian K. Albrecht, Jean-Christophe Harmange, David Bauer et al. · Journal of Medicinal Chemistry · 2008 · 139 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-related Mutations

Steven F. Bellon, Paula Kaplan‐Lefko, Yajing Yang et al. · Journal of Biological Chemistry · 2007 · 138 citations · Full text

Medicine, Oncology, Pharmacology +13

Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series

Longbin Liu, Mark H. Norman, Matthew Lee et al. · Journal of Medicinal Chemistry · 2012 · 78 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14